Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 20 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

142 DCE-MRI radiogenomics predicts immune microenvironment subtypes and neoadjuvant chemotherapy response in HR+/HER2− breast cancer

  1. 15 Department of Breast Surgery, Fujian Cancer Hospital, Fuzhou, China
  2. 2Department of Breast Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China

Related

  1. Relative change rate of neutrophil-to-albumin ratio (ΔNAR) during neoadjuvant chemotherapy predicts axillary pathological complete response in locally advanced breast cancer
    Yujie Zhao, Yuxiang Deng, Weicai Chen +4
    Gland SurgeryPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. Mammography based delta radiomics with machine learning predicts pathologic complete response after neoadjuvant chemotherapy in breast cancer
    Xiaohang Hu, Yanfang Liu, Yuan Gao +7
    Discover OncologyPeer-reviewedCC BYFull textMedical imaging & radiologyDOAJ
  3. Impact of neoadjuvant chemotherapy on the association between key genetic alterations and tumor microenvironment in upper tract urothelial carcinoma
    Daiki Ikarashi, Kenta Takahashi, Shigehisa Kitano +9
    Cancer Immunology, Immunotherapy : CIIPeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaPMC
  4. Skeletal muscle depletion during neoadjuvant chemoimmunotherapy predicts postoperative complications in non-small cell lung cancer: a retrospective cohort study
    Wei Feng, Xin Wang, Heng Du +1
    Journal of thoracic diseasePeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. Neoadjuvant chemotherapy in locally advanced colon cancer: lessons from the NeoCol trial and the limits of anatomical risk stratification.
    Mohamed Alkashty
    Annals of coloproctologyPeer-reviewedCC BY-NCFull textOncologyEurope PMC
BibTeX
@article{song2026dcemri,
  title = {{142 DCE-MRI radiogenomics predicts immune microenvironment subtypes and neoadjuvant chemotherapy response in HR+/HER2− breast cancer}},
  author = {Chuangui Song and Yushuai Yu and Ruiliang Chen},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0142},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0142},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 142 DCE-MRI radiogenomics predicts immune microenvironment subtypes and neoadjuvant chemotherapy response in HR+/HER2− breast cancer
AU  - Chuangui Song
AU  - Yushuai Yu
AU  - Ruiliang Chen
PY  - 2026
DA  - 2026/11/06
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0142
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0142
SN  - 2051-1426
ER  -